Skip to content
Subscriber Only

DSM Says ‘No Pause’ in Acquisitions as Profit Tops Estimates

Royal DSM NV, the world’s biggest maker of vitamins, said it is capable of pursuing other potential acquisitions even as it works to integrate its $1.09 billion purchase of Martek Biosciences Corp.

There will be “no pause” in the takeover strategy with other targets like Martek out there, Chief Financial Officer Rolf-Dieter Schwalb said on a call. First-quarter earnings beat estimates, sending DSM shares up the most in two years.